The clinical term for these studies is PrEP, which stands for Pre-Exposure Prophylaxis. All of the following studies involve PrEP. The studies with the soonest expected date of completion are the Ford Health System (June 30, 2020) and Duke University (July 2020).

Duke University : HERO HCQ Study

• Patient-Centered Outcomes Research Institute committing $50 million

• double-blind, placebo-controlled, randomized trial with treatment course of 30 days.

• 15,000 patients at 17 locations in 12 states

• Principal investigator: Adrian Hernandez, M.D., cardiologist and executive director of Duke Clinical Research Institute

• Estimated primary completion date: July 2020